Biohaven Pharma (BHVN) Tops Q3 EPS by 24c
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Join SI Premium – FREE
Biohaven Pharma (NYSE: BHVN) reported Q3 EPS of ($1.64), $0.24 better than the analyst estimate of ($1.88).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kronos Worldwide (KRO) Tops Q2 EPS by 17c
- South Bow Corporation (SOBO) Reports Q2 EPS of $0.50
- BioAmber (BIOA) Reports Q2 Loss of $0.58
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
